Direxion Daily Energy Bull 2X Shares ETF
ERX
Direxion Daily Real Estate Bull 3X Shares ETF
DRN
VanEck Oil Services ETF
OIH
4
iShares US Telecommunications ETF
IYZ
5
Energy Select Sector SPDR Fund
XLE
US Stock MarketDetailed Quotes
Mesa Royalty Trust (MTR)
- 5.145
- -0.005-0.10%
Trading Feb 20 09:56 ET
5.187High5.050Low
5.187High5.050Low6.50KVolume5.150Open5.150Prev Close33.19KTurnover0.35%Turnover Ratio20.75P/E (Static)1.86MShares10.12652wk High3.04P/B9.59MFloat Cap4.01252wk Low0.20Dividend TTM1.86MShs Float26.652Historical High3.83%Div Yield TTM2.66%Range %2.465Historical Low5.109Avg Price1Lot Size
MTR Stock Chart
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Mesa Royalty Trust (MTR) News
Mesa Royalty Trust Says No Distribution for February
Express News | Mesa Royalty Trust Announces There Will Be No Distribution for February 2026
Mesa Royalty Trust To Go Ex-Dividend On January 30th, 2026 With 0.00152 USD Dividend Per Share
Express News | Mesa Royalty Trust Announces Trust Income for January 2026
Press Release: Mesa Royalty Trust Announces Trust Income for January 2026
Oil Hits 7-Week High After Trump Tariffs Threat Sparks Concern Over Iran Supply
Mesa Royalty Trust (MTR) Stock Forum
In Life as in the Market, don’t be afraid to CUT YOUR LOSSES and cut the losers. Everybody can’t go 😏
.
BNB Blame NoBody - DYOR Do Your Own Research 🔬
.
🚨 Trade with Proper Equity Management, Mitigated Risk Management & Capital Preservation. Never trade on emotion nor trade any funds you can’t afford to lose. ⚠️
.
The market is in a volatility squeeze. some call it a...
.
BNB Blame NoBody - DYOR Do Your Own Research 🔬
.
🚨 Trade with Proper Equity Management, Mitigated Risk Management & Capital Preservation. Never trade on emotion nor trade any funds you can’t afford to lose. ⚠️
.
The market is in a volatility squeeze. some call it a...
+16
146
35
14
6
$Mesa Royalty Trust (MTR.US)$ $Sintx Technologies (SINT.US)$ $Cyclerion Therapeutics (CYCN.US)$ $Sharps Technology (STSS.US)$ $VCI Global (VCIG.US)$ $Jowell Global (JWEL.US)$ $Upexi (UPXI.US)$ $Unusual Machines (UMAC.US)$ $Digital Ally (DGLY.US)$ $Silexion Therapeutics (SLXN.US)$ $S&W Seed (SANW.US)$ $Exicure (XCUR.US)$ $Forte Biosciences (FBRX.US)$
📊⚡️📊
📊⚡️📊
3
Monthly distributions are expected to fluctuate based on production, oil and gas prices, and administrative expenses. Distributions will be materially reduced until the Trust increases its cash reserves to $2.0 million. The Trust's ability to pay distributions is affected by industry volatility and revenues and expenses reported by working interest owners.
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
MoonGazer : Awesome!
Coach Donnie OP MoonGazer : That you ARE my friend
Coach Donnie OP : Cathie Woods bought a ton!
Woods bought a ton today! more than ever in a day
Cathie
Thanks @10baggerbamm
Coach Donnie OP : Nancy Pelosi Trading Activity | Quiver Quantitative
Coach Donnie OP : KALV 12-50
$KalVista Pharmaceuticals (KALV.US)$ FDA is approval is almost guaranteed, i got time to wait Post approval 400-800m revenue is expected to make 2026 they start distribution works as trade or invest - FDA approval could be transformative for KalVista. Looking at peak revenue potential, EPS could swing from negative to well into double digits, with the stock realistically trading in the $20–$40+ range if execution aligns with expectations.
$KalVista Pharmaceuticals (KALV.US)$ FDA is approval is almost guaranteed, i got time to wait Post approval 400-800m revenue is expected to make 2026 they start distribution works as trade or invest - FDA approval could be transformative for KalVista. Looking at peak revenue potential, EPS could swing from negative to well into double digits, with the stock realistically trading in the $20–$40+ range if execution aligns with expectations.
View more comments...